| Date | Title | Description |
| 22.03.2021 | Lumira completes investment in XyloCor Therapeutics’ Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease | – Company closes additional $22.6 million in new financing – |
| 22.11.2017 | St. Joe’s receives research funding from Lumira Capital | The Research Institute of St. Joe’s Hamilton is set to receive philanthropic funding from Lumira Capital to support research initiatives at the hospital. |
| 08.06.2017 | Northleaf Venture Catalyst Fund Invests $15M in Lumira Capital; Closes $300M Program | Northleaf Venture Catalyst Fund (NVCF), a joint initiative between major Canadian institutional investors and the Governments of Canada and Ontario, has made a $15m lead commitment to Lumira Capital IV.
Lumira Capital IV a late-stage ventur... |
| 13.03.2017 | Platinum Equity Capital Partners IV Raises $6.5B | Platinum Equity announced today the close of Platinum Equity Capital Partners IV, a $6,500,000,000 global buyout fund.
The fund was heavily oversubscribed, driven by the success of Platinum’s highly specialized M&A&O® strategy that ... |
| 24.01.2017 | Exact Imaging artcle in Medical Device Daily | Learn More-External Link |
| 17.07.2016 | Endotronix Raises $32M Series C from Aperture Venture Partners | Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, announced that the company has closed a $32 million Series C round of financing. The investor syndicate brings toget... |
| 17.07.2016 | Endotronix Raises $32M Series C from BioVentures Investors | Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, announced that the company has closed a $32 million Series C round of financing. The investor syndicate brings toget... |
| 14.07.2016 | Endotronix Closes $32 Million in Financing to Address Heart Failure Management | WOODRIDGE, Ill., July 14, 2016 /PRNewswire/ — Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, today announced that the company has closed a $32 million Series C rou... |
| 08.01.2016 | Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline of Azymetric™ Antibody Therapeutics | Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline of Azymetric™ Antibody Therapeutics
January 08, 2016
Vancouver, Canada – Zymeworks Inc. today announced the closing of a US$ 61.5 million Series... |
| 24.11.2015 | Daily funding roundup - November 24, 2015 | Placester secured $27M; Shiftgig raised $22M; Fortscale announced $16M funding
Lenda, a first platform that allows homeowners to refinance their mortgage completely online, today announced the close of $2 million in seed funding led by Lake... |
| 18.11.2015 | First Aid Shot Therapy® (F.A.S.T) Completes $24 million Series C Financing | BURLINGAME, Calif., Nov. 18, 2015 /PRNewswire/ — First Aid Shot Therapy® (F.A.S.T.), a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid shot form (40ml / 1.35oz.), announced today that it has completed a Seri... |
| 17.12.2014 | Argos’ Unexpected ASH Presentation | Learn More-External Link |
| 01.10.2014 | Lumira makes investment in AvidBiologics Inc. | SOURCE: MaRS Innovation |
| 01.10.2014 | Lumira leads investment in Avid Biologics | Learn More-External Link |
| 29.07.2014 | Aurinia Adds Financial Expertise To Its Board Of Directors | Learn More-External Link |
| 16.04.2014 | Cardiac Dimensions Completes $20M Financing | Cardiac Dimensions, Inc., a Kirkland, Washington-based developer of minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, completed a $20m financing.
The round was led by M. H. Carnegie &... |
| 12.11.2013 | Lumira Capital Closes $10 Million Venture Capital Action Plan Investment | TORONTO, Nov. 12, 2013 – Lumira Capital announced today that it has closed on a new $10 million investment commitment for Lumira Capital II. The commitment comes from the Government of Canada via the Venture Capital Action Plan (VCAP) initi... |
| 02.08.2013 | enGene Raises $13.25M Financing | enGene Inc., a Montreal, Quebec, Canada-based pre-clinical stage biopharmaceutical company developing a platform technology for the delivery of nucleotides (DNA or RNA) to the gut, has held an initial closing of a $13.25m financing.
The rou... |
| 05.06.2013 | Lumira Capital announces investment in Vendorlink.ca | TORONTO, June 5, 2013 /CNW/ – Vendorlink.ca, the premier provider of web-based vendor management solutions for Canadian hospitals, announced today that it has completed a financing round which was led by Lumira Capital. Vendorlink.ca’s serv... |
| 21.12.2012 | Prudential Capital Partners IV closes $1.15bn mezzanine fund | The mid-market mezzanine arm of life insurance giant Prudential has beaten its $1bn target for its fourth fund. Prudenti |
| 25.10.2012 | Thrasos Therapeutics Completes $35M Financing | Thrasos Therapeutics, a Montreal, QC, Canada-based clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease, has completed a $35m financing.
Th... |
| 18.10.2012 | Why, when and how to approach a strategic investor for a healthcare startup | Before Medtronic acquired Ardian in 2010, it led a $47 million series C round for the company. Boston Scientific led an $11 million round for Intelect Medical two years before buying it for $78 million. According to some investors, these ki... |
| 26.03.2012 | Teralys Capital invests in two new Lumira Capital life sciences funds | SOURCE: Teralys Capital |
| 05.12.2008 | ViOptix snags $7.4M to measure tissue oxygen | Biotech firm ViOptix just tacked $4.4 million onto an already $12.2 million fourth round of funding and landed $3 million in debt financing to break even, reports VentureWire. The Fremont, Calif. company says this will be its last round of ... |
| 18.12.2007 | Cardiac Dimensions® Inc. Announces Closing of $35.5 Million Round of Financing. JJDC & Lumira Capital Co-Lead Round, Providing Funds to Be Used to Support FDA Clinical Trials of the CARILLON™ Mitr... | KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions®, Inc. announced today it has closed $35.5 million in new venture capital. This Series D financing was co-led by Johnson & Johnson Development Corp. (JJDC) and Lumira Capital, and inclu... |
| - | Why, when and how to approach a strategic investor for a healthcare startup | Before Medtronic acquired Ardian in 2010, it led a $47 million series C round for the company. Boston Scientific led an $11 million round for Intelect Medical two years before buying it for $78 million. According to some investors, these ki... |
